Hamostaseologie

Article	Citations
Mitteilungen aus der Vorstandsarbeit	63
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	30
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	28
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	23
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	21
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	21
	19
Mansoor’s self-report tool for cardiovascular risk assessment predicts adverse in-hospital events in patients with pulmonary embolism	18
Participation of T helper cell-mediated negative regulation of coagulation in human arterial thrombosis	17
Current diagnostic and therapeutic standard of iliac vein compression syndrome (May-Thurner syndrome) in children, adolescents and young adults. A survey among national thrombosis experts	16
Recombinant ADAMTS13 treatment in a pregnant patient with hereditary thrombotic thrombocytopenic purpura	15
Immune tolerance achievement by low dose factor VIII in PUPs and MTPs under prophylaxis with emicizumab: two case reports	14
Preanalytical quenching of FVIII using FVIII-inhibitors improves the specificity of functional emicizumab testing	13
Possible immune reaction to COVID-19 vaccination - a case report	10
Shifted TFPI/tissue factor balance drives paradoxically delayed thrombin initiation in active pediatric IBD	10
Diagnostic challenges of Thrombotic Thrombocytopenic Purpura: Results from a cohort of 3,100 individual patients in a time period of 21 months	10
Thrombopoietin external quality assessment – laboratory results and method precision	9
Von Willebrand Factor at the Crossroads of Hemostasis and Inflammation	9
Therapeutic options to treat immunothrombosis mediated by platelet activating histone/anti-histone immune complexes	9
Inter-laboratory comparison of plasma efanesoctocog alfa measurements	9
Gene Therapy of Haemophilia: Current Status and Future Directions	9
Knowledge graph-driven curation of heme-TLR4 interactions in inflammatory pathways	9
	9
Subsegmental Pulmonary Embolism	8
Komplementdysregulation als Biomarker für Post Covid	8

Development of Antidrug Inhibitory Antibodies against Polyethylene Glycol after Treatment with PEGylated Factor VIII Therapeutic	8
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	8
	8
Sulodexid: Neue Hoffnung bei retinalen Gefäßerkrankungen	8
Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II	7
A Survey on anticoagulation in patient with ITP	7
Insights in pain processing of affected versus non-affected structures	7
Impaired hemostatic capacity in patients with low von Willebrand factor	7
Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Follow-up evaluation of real-life-data documented by smart medication eDiary	7
Immune modulation by the endothelial protein C receptor (EPCR) in cancer progression	7
Platelets are pre-activated during thrombocytopenia in a subset of early malaria infections	6
Unexpected Loss of FVIII Recovery Due to Product-Specific Anti-Drug Antibodies in a Mild Hemophilia A Patient Treated with Efanesoctocog Alfa	6
Hemolysis-derived heme meets protein Z: Insights into a novel heme-binding anticoagulant protein	6
Histological characterisation of intraluminal thrombi from patients with abdominal aortic aneurysm	6
Connecting the Dots: Reflections on a vibrant Year in Haemostasis Research	6
Investigating the role of GABARAPs protein family in FVIII secretion	6
Novel humanized mouse model of heparin-induced thrombocytopenia	6
Association between FIX levels & bleeding rates in hemophilia B patients receiving rFIXFc or N9-GP	6
NXT007 prophylaxis in people with haemophilia A with or without FVIII inhibitors: a global phase I/II multiple-ascending-dose study.	6
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?	6
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	6
Hypofibrinogenemia is linked to hyperinflammation in patients receiving CAR T-cell therapy	6
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	6
Primäre Immunthrombozytopenie: Erhöhtes Krebsrisiko für Erwachsene	6
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	5
Patient-reported outcomes after upper-extremity deep vein thrombosis due to compression syndromes: A multinational longitudinal retrospective study	5
Use of concizumab in children with severe hemophilia B and factor IX-inhibitors	5
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	5
Adenoviral Core Protein VII-Driven Cross-Reactivity of Anti-PF4 Antibodies as a Trigger for VITT Pathogenesis	5
Platelet sensitivity to GPVI stimulation decreases during platelet recovery after apheresis	5
Clinical outcome and cost analyses in adult patients with acquired hemophilia A- a single center, retrospective analysis.	5
	5
Altered plasma factors in congenital thrombophilia suppressing platelet glycoprotein VI activation	5
Platelet Dynamics and Clinical Outcomes in Patients with Heparin-Induced Thrombocytopenia – Single Center Experience	5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	5
Vitamin D deficiency in adult patients with primary immune thrombocytopenia (ITP) from the Vienna ITP Biobank	4
Management of Antithrombin Deficiency in Pregnancy	4
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	4
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	4
Influenza infections destabilize established immune tolerance in HemA mice	4
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score	4
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	4
Evaluating the individual risk of venous thrombo-embolism in patients with liver cirrhosis: Usefulness of in vivo and ex vivo thrombin generation parameters	4
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	4
Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemost	4
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	4
Reference Intervals in Coagulation Analysis	4
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien	4
Comprehensive DIA-MS profiling of clot and plasma proteomes across immune- and coagulation-deficient mouse models	3
A new rapid automated clotting assay enables measurement of residual TFPI activity in human plasma	3

On Factor VIII Assay Discrepancies in Post-infusion Samples Obtained from Patients Treated with Efanesoctocog Alfa	3
Clinical and Genetic Spectrum of Hereditary Antithrombin Deficiency: Correlation of Type, Functional Activity, and Arterial Thrombotic Risk	3
Measurement of procoagulant platelets in platelet-rich plasma by flow cytometer for the diagnosis of heparin-induced thrombocytopenia	3
Risk Factors for the Progression of Haemophilic Arthropathy – The PUSH-Study	3
Immune Response Mechanisms in Haemophilia A	3
Antidepressant Agent Use and Risk of Bleeding in Patients with Cancer: Results from the Vienna CAT-BLED study	3
Plasma proteomics and collagen biomarkers in people with haemophilia A receiving emicizumab in STASEY	3
Impact of recalcification on procoagulant COAT platelet generation in PRP samples with low platelet counts	3
Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etr	3
Survey on the care reality of people with mild hemophilia A and B in Germany - the burden of mild hemophilia	3
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	3
Decoding the Fibrinogen γβ Nodule (D-Region): First Cryo-EM Insights Toward the Full Hexameric Structure	3
Mild Factor XI Deficiency in Women with Hypermenorrhea or Prolonged Postoperative Bleeding: A Genotype–Phenotype Analysis	3
A novel single chain antibody inhibiting lateral fibrin interactions thereby remodeling fibrin clot architecture and accelerating thrombolysis	3
EMIIL - Non-interventional study to investigate the effectiveness of Emicizumab under real-world conditions in pediatric, adolescent, adult and elderly patients with hemophilia A (PwHA) with and witho	3
Diagnostic Challenges in Acquired Hemophilia A with Concomitant Oral Anticoagulant Use: A Case Series Analysis	3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	3
In vivo modulation of the protein C pathway by THBD and PROCR gene variants	2
Inhibition of cold-induced apoptosis of platelet concentrates improves platelet functionality and half-life	2
Telomere length is associated with increased risk of cardiovascular events in hemodialysis patients	2
Prediction of brain cancer-associated thrombosis by imaging-based machine learning: Results from the Vienna Cancer and Thrombosis Study	2
Elevated plasminogen activator inhibitor-1 is not associated with impaired plasmin formation and thrombotic risk after low-grade coagulation activation in vivo	2
Pharmazeutische Unternehmen außerhalb der USA unter Druck	2
From Case Reports to Cohort Studies: The Many Faces of Clinical Research in Thrombosis and Haemostasis	2
Endothelial protein C receptor signaling regulates myeloid-biased hematopoiesis under stress and in aging	2
Improved blood analysis panel for the early detection of thromboses and thrombotic risk factors	2
HEM-POWR study: Subgroup analysis evaluating the real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Germany	2
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	2
Temporal phosphoproteomics reveals key regulators of procoagulant COAT platelet generation	2
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall	2
Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer	2
Navigating the Diagnostic and Clinical Spectrum of Thrombocytopenia and Thrombocytopathy: Lessons from a Case Series	2
Endogenous FVIII activity and procedure-related FVIII use and bleeding: post hoc analysis of GENEr8-1	2
GTH News	2
Non-clinical pharmacodynamic effects and immunogenicity assessment of prophylactic immune modulation prior to gene therapy dose administration in C57BL/6 mice	2
Recurrent Venous Thrombosis in a Hypofibrinogenemic Patient Despite a Heterozygous Deletion of the Fibrinogen Gene Cluster and Hemizygous FGB p.Pro265Leu Variant Mimicking a Homozygous Genotype	2
Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors	2
Digital joint discovery tool to support hemophilia patient education	2
Treatment of Inherited Platelet Disorders: Current Status and Future Options	2
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)	2
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	1
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	1
Correlation between coagulation factor residual activities and detection rate of diseasecausing variants in Rare Bleeding Disorders	1
In vitro haemostatic functionality of INTERCEPT (Amotosalen, UVA) pathogen-reduced platelet concentrates is not affected by cold-storage	1
The effect of prophylactic corticosteroid treatment on adeno-associated virus-mediated gene therapy and potential mechanisms of action	1
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-19	1
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	1
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	1
Prevalence of Synovial Hypertrophy in 428 Patients with Haemophilia A	1
Real-World Effectiveness and Usage of Recombinant Factor IX Fc: Final Data from the B-MORE Study	1
Sequential combinations of rapid immunoassays for quick recognition of heparin-induced thrombocytopenia	1
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	1
Venous Thromboembolism Issues in Women	1
NET formation contributes to clinical relapses but not ADAMTS13 biomarker relapses in immune-mediated thrombotic thrombocytopenic purpura	1
The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation	1
Ontogeny of peripheral blood platelet GPIIb/IIIa activation and granule release in preterm and term neonates	1
Saliva and urine from persons with hemophilia A trigger coagulation bypassing factor VIII	1
Identification of key regulators of procoagulant COAT platelet generation by quantitative phosphoproteomic analysis and phosphoflow	1
Interim 52-Week analysis of immunogenicity to the vector capsid and transgene-expressed human FVIII in GENEr8-1, a phase 3 clinical study of valoctocogene roxaparvovec, an AAV5-mediated gene therapy f	1
Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia) Activity Using Reagent-/Platform-Specific Conversion Factors	1
The Use of Large Animal Models in Trauma and Bleeding Studies	1
Bleeding Risk in Patients with Cancer	1
Extravascular distribution of factor IX: evidence and relevance for hemophilia B replacement therapy	1
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	1
Analysis of Soluble and Humoral Immunological Parameters During Re-exposure with rFVIIIFc after History of Inhibitors	1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	1
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	1
Subsequent vaccinations in VITT patients other than SARS-CoV2 vaccination	1
Direct oral anticoagulation in transplant recipients – long-term Follow-up from the Prospective Dresden NOAC Registry (NCT01588119)	1
Treatment of a patient with von Willebrand disease type 2B and severe thrombocytopenia due to mutation p.V1316M with thrombopoietin receptor agonist Avatrombopag	1
Periinterventional management of edoxaban in major procedures: results from the DRESDEN NOAC REGISTRY	1
Impact and dynamics of monocyte and platelet activation on clinical outcomes in patients under immune checkpoint inhibitors.	1
The Timed Up and Go Test in Patients with Haemophilia: Assessing Reliability, Validity, and Predictive Variables	1
	1
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Crovalimab as Add-On Therapy in Patients with Antiphospholipid Syndrome and Recurrent Thrombosis	1
Clinical Course and Outcomes of Thrombotic Thrombocytopenic Purpura in Young Adults with Systemic Lupus Erythematosus: A Case Series from a Tertiary Hospital	1
Efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer	1
Antiboby mediated Acquired Glanzmann Thrombasthenia – a diagnostic and therapeutic challenge – with Concizumab as Promising Therapeutic Approach: A Case Report	1
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	1

Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Platelet hyperactivation and neutrophil extracellular traps promote thrombo-inflammation and glomerular endothelial dysfunction in diabetic kidney disease	0
	0
Correction: Oxidative Stress, NADPH Oxidases, and Arteries	0
GTH News	0
	0
Alternative polyadenylation regulates VEGF-coreceptor NRP1	0
International normalized ratio (INR) and aPTT values associated with dabigatran plasma levels≤20 ng/ml – Development and validation of a predictive model including 164 patients.	0
Blutverlust bei Frauen im gebärfähigen Alter aufgrund oraler Antikoagulanzien gegen venöse Thromboembolien	0
Disorders of Thrombosis and Hemostasis in Cancer	0
Monitoring of argatroban in COVID-19 ICU patients: a prospective study comparing aPTT, point-of-care viscoelastic testing with ECA-test and dTT to LC/MS/MS	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0
Welcome	0
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
G-BA entscheidet Festgruppe für (plasmatischen) Blutgerinnungsfaktor VIII	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Novel Ultrasound Markers of Synovial Tissue Function to Differentiate the Severity of Synovial Proliferation in Patients with Hemophilia: A Cross-Sectional Analysis	0
P2Y12-Inhibitoren hemmen Thrombozyten-induzierte Monozytenaktivierung	0
Pitfalls in Coagulation Testing	0
VTE Risk Assessment and Prevention in Pregnancy	0
Platelet responsiveness in the post-acute phase of pulmonary embolism	0
The impact of enhanced platelet turnover on platelet reactivity in healthy humans	0
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
Simultaneous detection of factor VIII and emicizumab	0
Treatment of Bleeding Episodes with Efanesoctocog Alfa in Children: XTEND-ed Second Interim Analysis	0
Haemostaselogy meets Gender-medicine – Pulmonary embolism in girls	0
Mitochondrial Calcium Uniporter: A Potential Target to Modulate Procoagulant Platelets	0
Involvement of GPVI in FVIII-platelet interactions and PS exposure	0
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
Evolution of joint health and physical activity in people with haemophilia A without factor VIII inhibitors switching to emicizumab prophylaxis: 12-month interim analysis of the BEYOND ABR study	0
Pulmonary Embolism: Don't Start Me to Talkin'	0
A hierarchical network of Src, Syk, Btk and PKC controls GPVI-dependent human platelet activation	0
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	0
The phenotypic and genetic assessment of hereditary antithrombin deficiency in 215 patients from the Rhein-Ruhr area in Germany	0
Direct Oral Anticoagulants for Pulmonary Embolism	0
	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
Platelet GPIIbIIIa enriched membrane protrusions (Tether) in healthy and diseased individuals	0
Procoagulant Platelets and Thrombin Generation in Glanzmann Thrombasthenia: Insights into Bleeding and the Failing Compensatory Mechanism with Desmopressin on Platelets	0
Grundlagen zur Anwendung von Andexanet	0
The Post-VTE Functional Status Scale for assessment of functional limitations in patients with venous thromboembolism: construct validity and responsiveness in a prospective cohort study	0
Phase 3 study of the efficacy, pharmacokinetics, immunogenicity and safety of von Willebrand Factor/Factor VIII concentrate in patients with severe von Willebrand Disease under 6 years of age	0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
Comparative transcriptome profile analysis on early T2DM-aggravated atherosclerotic mouse aortas	0
	0
Structure functional insights on FXIII-B subunit from models and biophysical structures.	0
High Prevalence of F2 20210G > A in Splanchnic Vein Thrombosis and Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study of Patients with Thrombosis in Atypical Sites	0
Relation of FVIII activity levels with global assays of hemostasis in persons with hemophilia A	0
Association of age with the ISTH-BAT score and prevalence of bleeding symptoms in patients with bleeding disorder of unknown cause: results from the Vienna bleeding biobank	0
Potenzielle globale Gerinnungsparameter für Therapiemonitoring unter Emicizumab	0
At the forefront of the introduction of gene therapy in hemophilia A and B: Design and implementation of an innovative software platform ("smart medication Gene") for gene therapy	0
Agenesis of vena cava inferior (AVCI) and Hypereosinophilic Syndrome (HES): two rare causes of severe thrombosis and its challenging treatment in adolescents	0
Direct Oral Anticoagulants: Laboratory Challenges and Antidotes	0
Gut Microbiota as a Modulator of Age-related Arterial Thrombosis	0
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	0
Impaired thrombin generation as a reproducible feature of bleeding disorder of unknown cause	0
Efficacy and Safety of Marstacimab in Participants With Severe Hemophilia A or B Without Inhibitors: Hemophilia Subgroup Results From the Phase 3 BASIS Trial and its Open-Label Extension	0
Factor VIII assay discrepancies in post-infusion samples obtained from patients treated with efanesoctocog alfa	0
Congenital Dysfibrinogenemia with Recurrent Venous Thrombosis and Concomitant von Willebrand Syndrome: A Case Report	0
Aggregates of non-muscle myosin IIA in the erythrocytes associate with GATA1-related thrombocytopenia	0
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
Randomized-controlled cross-over pilot study on the effectiveness of manual lymphatic drainage in patients with hemophilic arthropathy	0
The effect of DNA methylation on inhibitor development in haemophilia A patients treated with FVIII concentrates	0
Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal Antibody	0
	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
Leveraging medical-AI to speed up Cold Agglutinin Disease detection	0
Postthrombotisches Syndrom: SOX-PTS-Score und Méan-Modell zeigen beste Prädiktion	0
Cytokine dynamics following joint injury in hemophilia A mice	0
Assessment of platelet abnormalities in patients with DiGeorge Syndrome by immunofluorescence microscopy on the blood smear	0
Defining indications for thrombophilia testing – a modified Delphi consensus study in Switzerland	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Evaluation of the protein C pathway in critically ill patients with severe COVID-19 as compared to bacterial sepsis	0
Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI Activity	0
Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria	0
	0
Immunofluorescence microscopy of the blood smear in myeloproliferative neoplasms	0
Laboratory Findings, Medical Imaging, and Clinical Outcome in Children with Cerebral Sinus Venous Thrombosis	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Thromboprophylaxis in pregnant Women with a History of Venous Thromboembolism and/or Thrombophilia – Demographic Data and Implementation of Pharmacological Thromboprophylaxis: Preliminary Results from	0
	0
Utility of ACMG classification to support interpretation of molecular genetic test results in patients with FVII deficiency	0
Update on Cancer-Associated Venous Thromboembolism in Children	0
Developing an assay to distinguish between HIT and VITT antibodies	0
IMPROVE: Identifying Molecular Determinants to Personalize Response and Optimize Treatment in von Willebrand Disease and Hemophilia	0
Defective platelet PAR1 signaling is associated with perioperative bleeding and impaired host defense	0
Postpartum acquired hemophilia A in two women with previously undiagnosed von Willebrand disease type 2N -unraveling two rare diagnoses	0
Glycoprotein-specific antibodies induce distinct platelet destruction pathways in ITP	0
Overview on Rare Congenital Bleeding Disorders and Epidemiological Data from the German Haemophilia Registry (DHR) and a Survey in Germany, Austria, and Switzerland	0
Laboratory Monitoring in Patients Receiving Emicizumab	0
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec (CSL222) vs. extended half-life Factor IX therapies for severe or moderately severe hemophilia B	0